The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review

被引：0
|
作者：
Jonathan Adachi
Niall Lynch
Hans Middelhoven
Manjit Hunjan
Warren Cowell
机构：
[1] McMaster University,Health Outcomes Research
[2] Global Health Outcomes,Healthcare Management
[3] Economic Value Strategy,undefined
[4] GlaxoSmithKline UK Ltd,undefined
[5] Roche Products Limited,undefined
来源：
BMC Musculoskeletal Disorders | / 8卷
关键词：
Vertebral Fracture; Fracture Risk; Alendronate; Osteoporotic Fracture; Risedronate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Antiretroviral therapy: the association between knowledge and the compliance
    de Andrade Moraes, Danielle Chianca
    Oliveira, Regina Celia
    Salvador da Motta, Maria Catarina
    Cardoso Ferreira, Oscar Luiz
    Andrade, Maria Sandra
    REVISTA DE PESQUISA-CUIDADO E FUNDAMENTAL ONLINE, 2015, 7 (04): : 3563 - 3573
  • [42] ASSOCIATION BETWEEN BISPHOSPHONATE THERAPY AND REHABILITATION OUTCOMES IN OLDER PEOPLE
    Goodbrand, J. A.
    Hughes, L. D.
    McMurdo, M. E. T.
    Donnan, P. T.
    Frost, H.
    McGilchrist, M.
    Cochrane, L.
    Witham, M. D.
    AGE AND AGEING, 2014, 43 : 21 - 21
  • [43] Association between bleeding risk and persistence on warfarin therapy in patients with VTE in clinical practice
    Kaatz, S.
    Fu, A. C.
    AbuDagga, A.
    LaMori, J. L.
    Bookhart, B. K.
    Damaraju, C., V
    Tan, H.
    Schein, J.
    Nutescu, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 948 - 948
  • [44] The impact of dosing frequency on use of bisphosphonate therapy among post-menopausal women: A comparison of compliance and persistence between UK and US cohorts
    Lynch, N. O.
    Walker, M.
    Cowell, W.
    Rigney, U.
    Suppapanya, N.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S78 - S79
  • [45] PERSISTENCE, COMPLIANCE AND BISPHOSPHONATE SWITCHING IN PATIENTS WITH MULTIPLE MYELOMA (MM) IN GERMANY
    Intorcia, M.
    Ansorge, S.
    Giannopoulou, C.
    Hohmann, D.
    VALUE IN HEALTH, 2017, 20 (09) : A463 - A463
  • [46] Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis
    Cramer, JA
    Amonkar, MM
    Hebborn, A
    Altman, R
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (09) : 1453 - 1460
  • [47] The contribution of persistence and compliance with bisphosphonates on fracture outcomes
    Rietbrock, Stephan
    Olson, Melvin
    van Staa, Tjeerd P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S78 - S78
  • [48] Real-world Adherence and Persistence with Bisphosphonate Therapy in Postmenopausal Women: A Systematic Review
    Fardellone, Patrice
    Lello, Stefano
    Cano, Antonio
    Moreira, Eloisa de Sa
    de Oliveira, Renato Watanabe
    Julian, Guilherme Silva
    Tang, Boxiong
    CLINICAL THERAPEUTICS, 2019, 41 (08) : 1576 - 1588
  • [49] Adherence to bisphosphonate therapy is associated with decreased nonvertebral osteoporotic fracture risk.
    Silverman, S
    Siris, E
    Abbott, T
    Barr, C
    Harris, S
    Rosen, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S286 - S286
  • [50] Increased Imminent Fracture Risk in Liver Transplant Recipients Despite Bisphosphonate Therapy
    Begin, Marie-Josee
    Ste-Marie, Louis-Georges
    Huard, Genevieve
    Dorais, Marc
    Rakel, Agnes
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (03) : 576 - 585
12345